Chest Compression Synchronized Ventilation (CCSV) during cardiac arrest in animals and humans: A scoping review

BackgroundVentilation during cardiopulmonary resuscitation (CPR) should be effective. Chest Compression Synchronized Ventilation (CCSV) is a novel approach aimed at optimizing gas exchange and hemodynamics by synchronizing mechanical ventilation with chest compressions. However, its clinical value, safety profile, and implementation barriers remain unclear. We thus aimed to systematically synthesize existing evidence on the use of CCSV during cardiac arrest in animals and humans. MethodsWe conducted a scoping review and systematically searched five databases (Medline, Embase, CENTRAL, Scopus, Web of Science) up to May 2025. Studies investigating CCSV or mechanistically related ventilation strategies during cardiac arrest were included regardless of study design, language, or publication date. Data were charted for study characteristics, outcomes, and adverse events. ResultsThirty-one studies published between 1980 and 2025 were included. Most were animal studies (n=19), primarily conducted in pigs, with limited human data (n=9). CCSV showed favorable effects on arterial oxygenation, carbon dioxide clearance, and hemodynamic parameters. Some studies reported improved return of spontaneous circulation and cerebral oxygenation compared to conventional ventilation modes. Adverse events such as pneumothorax and lung injury were inconsistently reported and mostly limited to animal models. ConclusionsAvailable data on CCSV suggests potential physiological benefits during CPR, particularly in experimental settings. Human data remain scarce, and larger, prospective human trials are essential to evaluate clinical effectiveness, guide implementation, and assess risks compared to conventional ventilation strategies.